Kintara Therapeutics, Inc. (NASDAQ:KTRA – Get Rating) was the recipient of a large decline in short interest in April. As of April 15th, there was short interest totalling 22,200 shares, a decline of 12.9% from the March 31st total of 25,500 shares. Based on an average daily trading volume, of 25,900 shares, the days-to-cover ratio […]